Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -64.60x is 83% below its 1-year average of -35.32x, near the low end of its 1-year range (-64.60x–-6.05x).
As of the fiscal period ended Tuesday, June 30, 2020.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-64.60x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-913.33%
vs the sector median at left
LENZ Therapeutics, Inc.
Market Cap
$120.28M
Interest Coverage Ratio
-64.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$119.87M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$121.25M
Interest Coverage Ratio
-41.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$118.75M
Interest Coverage Ratio
N/A
TTM Avg
30.61x
3Y Avg
29.12x
5Y Avg
24.09x
Market Cap
$118.65M
Interest Coverage Ratio
-405.70x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$116.58M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$124.98M
Interest Coverage Ratio
-1412.39x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. (LENZ) | $120.28M | -64.60x | N/A | N/A | N/A |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $119.87M | N/A | N/A | N/A | N/A |
| Seer, Inc. (SEER)vs › | $121.23M | N/A | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $121.25M | -41.14x | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $118.75M | N/A | 30.61x | 29.12x | 24.09x |
| Spruce Biosciences, Inc. (SPRB)vs › | $118.65M | -405.70x | N/A | N/A | N/A |
| Cibus, Inc. (CBUS)vs › | $122.13M | -1.90x | N/A | N/A | N/A |
| Coya Therapeutics, Inc. (COYA)vs › | $116.58M | N/A | N/A | N/A | N/A |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.98M | -1412.39x | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $125.45M | -50.85x | N/A | N/A | N/A |
Interest Coverage
-64.6x
Debt/Equity
0.00
Current Ratio
13.55
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2020-06-30 | -64.60x |
| 2020-03-31 | -6.05x |
